Literature DB >> 5126239

Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States.

G G Jackson, G Arcieri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5126239     DOI: 10.1093/infdis/124.supplement_1.s130

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  37 in total

Review 1.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Serum levels of gentamicin at peak and trough in neonates and infants.

Authors:  M Shahidullah; M Q Talukder; A K Chowdhury; S Ali; A Rashid
Journal:  Indian J Pediatr       Date:  1991 Mar-Apr       Impact factor: 1.967

3.  Comparative ototoxicity of amikacin and gentamicin in cats.

Authors:  E F Christensen; J C Reiffenstein; H Madissoo
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

4.  In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.

Authors:  T C Eickhoff; J M Ehret
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

5.  Release of gentamicin from acrylic bone cement.

Authors:  L Bunetel; A Segui; M Cormier; E Percheron; F Langlais
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

6.  Gentamicin dosage in children.

Authors:  M Taylor; C Keane
Journal:  Arch Dis Child       Date:  1976-05       Impact factor: 3.791

7.  Therapeutic drug monitoring.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

Review 8.  Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.

Authors:  P Noone
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

Review 9.  Why monitor serum levels of gentamicin?

Authors:  M Barza; M Lauermann
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

10.  Netilmicin: clinical efficacy, tolerance, and toxicity.

Authors:  A P Panwalker; J B Malow; V M Zimelis; G G Jackson
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.